ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Other Current Assets
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Other Current Assets of $2.49 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2015-12-14
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for the quarter ending 2015-09-30 was -$2.90M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for the quarter ending 2015-06-30 was -$320.75K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for the quarter ending 2014-09-30 was -$125.36K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for the quarter ending 2014-06-30 was -$67.36K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for fiscal 2015 was $2.49K, a 81.24% decline from fiscal 2014.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for fiscal 2014 was $13.29K, a 633.68% increase from fiscal 2013.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other current assets for fiscal 2013 was $1.81K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$3.22M derived: sum of 2 quarters · filed 2015-12-14 | $2.49K 10-K · filed 2015-12-14 | |
| 2015-06-30 | -$320.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $2.90M 10-Q · filed 2015-08-04 | ||
| 2015-03-31 | $3.22M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | -$125.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$192.72K derived: sum of 2 quarters · filed 2015-12-14 | $13.29K 10-K · filed 2015-12-14 | |
| 2014-06-30 | -$67.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $138.65K 10-Q · filed 2015-08-04 | ||
| 2014-03-31 | $206.01K 10-Q · filed 2015-05-11 | |||
| 2013-09-30 | $1.81K 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |